Cyanocobalamin Injection Dosage for Vitamin B12 Deficiency
For treating vitamin B12 deficiency, the recommended dosage of cyanocobalamin injection is 1000 mcg intramuscularly daily for days 1-10, followed by monthly maintenance injections. 1
Initial Treatment Regimen
The dosage and administration schedule for cyanocobalamin injections depends on the severity of the deficiency and the underlying cause:
Standard initial treatment (loading dose):
Route of administration:
- Intramuscular (IM) is the preferred route
- Note: Cyanocobalamin should NOT be given intravenously as there is little opportunity for liver storage due to rapid excretion in urine 1
Maintenance Therapy
After the initial loading phase, patients require ongoing maintenance therapy:
- Standard maintenance dosage: 1000 mcg intramuscularly once monthly 1, 3
- For patients with pernicious anemia: Lifelong monthly injections are required regardless of dietary changes 3
Special Considerations
Alternative Oral Therapy
High-dose oral supplementation may be considered as an alternative to injections in certain cases:
Oral dosing options:
Efficacy of oral therapy:
Patient-Specific Considerations
Pernicious anemia: Recent evidence shows that oral supplementation with 1000 μg/day of cyanocobalamin can improve B12 deficiency in pernicious anemia patients, though intramuscular administration remains the standard approach 6
Individualized frequency: Up to 50% of individuals with malabsorption may require more frequent administration than the standard monthly regimen, ranging from every 2-4 weeks to maintain symptom control 5
Monitoring Response
- Assess vitamin B12 status after 1-3 months of supplementation 3
- Monitor for clinical improvement of symptoms
- Regular monitoring of B12 status is essential, with annual assessment recommended for patients on maintenance therapy 3
Common Pitfalls to Avoid
- Underdosing: Using 100 mcg injections instead of 1000 mcg provides inadequate vitamin retention with no cost or toxicity advantage 2
- Inappropriate route: Administering cyanocobalamin intravenously should be avoided 1
- Inadequate duration: Failing to continue maintenance therapy in patients with pernicious anemia or other malabsorption conditions
- Relying solely on serum B12 levels: Response to treatment should be based on clinical symptoms rather than just laboratory values 5